Navigation Links
DNA- A Dependable Determinant to Select Treatment Plan for Alcoholics

Wendy Ooteman a Dutch researcher has stumbled upon some very interesting results following her study in pursuit of understanding// the biological and genetic characteristics of alcoholics, which ultimately determine which drugs can be used to curb the irresistible urge to drink.

The urge to consume alcoholic drinks can be stifled with drugs like Naltrexone and Acamprosate. The investigations done by the researcher highlights which characteristics of a patient determines the choice of drug.

The overpowering urge which compels an alcoholic to drink, not only ensnares him but also makes it more difficult for him to shake off this intense grip These insatiable craving for alcohol can be curbed using Naltrexone, which works by the use of conditioning the brain to receive an incentive or reward, and Acamprosate which works by means of the stress system. The drugs named here may not be sufficient for every patient. The query that was raised during the study was if the behavior patterns or characteristics of patient can determine which drug suits him.

Source-Eurekalert
'"/>




Page: 1

Related medicine news :

1. More Dependable Screening Test For Bladder Cancer
2. Residential Locality, A New Determinant Factor For Weight Gain
3. Age and Socioeconomic Factors Are Strongest Determinants of Sunburn
4. Selective eating just an evolutionary trait?
5. New Study Questions Cannibalism As A Worldwide Selective Force
6. Govt to Pass Amendment to Curb Sex Selective Abortions: Ramadoss
7. Malaysia Likely To Outlaw Gender Selection Test
8. UK Government to Outlaw Sex Selection of Babies
9. Parental Role In Embryo-Selection Urged
10. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
11. Fertility Clinics Allowing Parents To Select Gender
Post Your Comments:
(Date:12/7/2009)... CAE, officially has begun his work as the new worldwide ... ... Horsham, PA, USA (Vocus) December 4, ... officially has begun his work as the new worldwide executive ... the executive vice president of the American Society of Plastic ...
(Date:12/7/2009)... Centers for Disease Control and Prevention (CDC) announced the ... was designed to highlight the importance of flu vaccinations, ... additional steps to keep you and your family healthy ... January and beyond. ,, "It,s easy to get overwhelmed ... both seasonal and swine flu," said Dr. Laura Jana, ...
(Date:12/7/2009)... may be able to reverse some of the damage ... putting down their cigarettes, according to research out of ... The research is published in the December 15 issue ... Respiratory and Critical Care Medicine . , "We found ... thickness of the epithelium, or lining, of the airways ...
(Date:12/6/2009)... mainstay of multiple myeloma treatment may outperform alternative ... who have received stem cell transplants from unrelated, ... results to be presented by , Dana-Farber ... Hematology,s (ASH) annual meeting on Sunday, Dec. 6 ... 243-245, 5:45 pm CT). , The trial ...
(Date:12/6/2009)... researchers from the Medical College of Wisconsin, in Milwaukee, ... and other sickle cell disease complications in children. Barriers ... and patients were also identified. The study led ... pediatrics at the Medical College and Children,s Research Institute ... at the American Society of Hematology meeting Dec. 7, ...
Breaking Medicine News(10 mins):Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2
... ... - ... - Company to Host Conference Call Today ... (Nasdaq: MEMY ) today announced positive top-line data from the,randomized, placebo-controlled, multi-center ...
... Pharma, Inc.,(Nasdaq: IDMI ) today announced the presentation ... in patients,with lung metastases as a result of the ... that typically affects children and young,adults. The data show ... and exhibited signs of disease control. "These results ...
... New film delivers permanent static dissipative performance while complying ... with both European and US applicable ... the company that,manufactures flexible containment systems for the pharmaceutical ... they have developed a,revolutionary new film for use in ...
... Mich., Nov. 1 Perrigo Company,(Nasdaq: PRGO ... Ltd.,("Dexcel"), Perrigo,s partner for store brand OTC 20mg ... with AstraZeneca (the,manufacturer of Prilosec OTC(R)) involving three ... the product. While terms and conditions of the,agreement ...
... MannKind Corporation,(Nasdaq: MNKD ), focused on discovering, developing and ... present at,the following conferences: * The Acumen BioFin Rodman ... Tuesday November 6, 2007 at 2:20 PM ET at the ... NY., * The CIBC 18th Annual Healthcare Conference on ...
... HARRISBURG, Pa., Nov. 1 To mark the start ... today urged,Pennsylvanians to adopt healthy habits that may help ... a chronic disease that affects an estimated 21 million,Americans ... is a serious, public health concern with causes linked ...
Other Medicine News:Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 2Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 3Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 4Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 5Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 6Health News:Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease 7Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 2Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 3Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 4Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 5Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 6Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 7Health News:ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 3Health News:Health Secretary Promotes Awareness of Diabetes, Urges Healthy Habits 2
(Date:12/4/2009)... Dec. 4 The U.S. Food and ... form as an option for the treatment of schizophrenia ... disorder in adolescents aged 13-17 years old. ,, ... into consideration the increased potential for weight gain and ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Management Health Solutions Inc to Exhibit at HFMA ANI 47574 1Management Health Solutions Inc to Exhibit at HFMA ANI 47574 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 1HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 3HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 4New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 1New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 2
... Provides Real-Time Insight on Viability of Infectious ... Disease Treatment Options -, ... ) today announced that the Texas A&M Health,Science Center Research Foundation ... of more effective therapeutic,treatments for tuberculosis. Research efforts and the purchase ...
... Terumo Heart, Inc. announced,a presentation at the ... "Long Term Circulatory Support with the DuraHeart(TM) ... Eligible for,Transplantation: European Experience" was delivered by ... Terumo Heart, Inc., (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 ...
Other Medicine Technology:Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center 2Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
With this more compact transducer face, this is the transducer of choice for obstetric imaging in areas with a small acoustic window....
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
... The OPTI LION is a compact ... single-use cassettes instead of reagents or ... patient sample is analyzed., ,In addition ... the OPTI LION measures ionized calcium ...
Medicine Products: